Cutler Group LP Evelo Biosciences, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$2.66 - $6.63 $13,222 - $32,957
-4,971 Reduced 81.88%
1,100 $3,000
Q4 2021

Jan 18, 2022
BUY
$6.07 - $12.0 $15,618 - $30,876
2,573 Added 73.56%
6,071 $36,000
Q3 2021

Oct 26, 2021
BUY
$6.79 - $13.9 $23,751 - $48,622
3,498 New
3,498 $24,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email